ArticleCureus2026

The Price of Remission: Modeling the Total Financial Burden, Quality-of-Life Impairment, and Healthcare Dependence in Lupus Compared With Chimeric Antigen Receptor (CAR) T-cell Therapy.

Kareena Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.